PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT 4 | $0.195 -15.0% 56K

(0.0% 1d) (-4.0% 1m) (35.7% 1y) (0.0% 2d) (0.0% 3d) (13.4% 7d) (229.42% volume)
Earnings Calendar:
Market Cap: $ 81,801,938
http://www.provectusbio.com/
Sec Filling | Patents | 2 employees

(US) provectus biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. provectus’ investigational oncology drug, pv-10, is an ablative immunotherapy under investigation in solid tumor cancers.

add to watch list Paper trade email alert is off

Press-releases

Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| Email alert Add to watchlist
rose publication tumor preclinical for

Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| 13.43% | O: 0.0% H: 7.58% C: 7.4%
BMO | News | $92.14 1.24% 0.0% 310K

Finance

| -1.81% | O: -1.84% H: 0.0% C: -1.03%
management

Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| 11.96% | O: 0.0% H: 17.21% C: 7.19%
pv-10 presentation cancer immunotherapy for meeting

Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| -3.55% | O: -0.91% H: 5.79% C: 2.46%
rose license worldwide treatment eye infections agreement

Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| -6.63% | O: 3.19% H: 4.62% C: 1.71%
award rose tumor

Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| 11.76% | O: 0.59% H: 28.01% C: 24.68%
pv-10 cancer immunotherapy meeting

Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| 30.05% | O: 0.21% H: 1.71% C: 1.57%
rose presentation meeting

Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
Published: 2024-02-15 (Crawled : 13:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| 39.3% | O: -4.4% H: 4.68% C: 4.14%
first conference

Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
PVCT 4 | $0.195 -15.0% 56K

Manufacturing

| 42.32% | O: 0.52% H: 1.64% C: 1.64%
services